scholarly journals RESEARCH OF CANCER CASES AMONG LONG-LIVED WOMEN IN LVIV REGION (UKRAINE) DURING 1991–2019 YEARS

Author(s):  
Nataliya Kitsera ◽  
◽  
Yaroslav Shparyk ◽  
Orest Tril ◽  
Zoriana Dvulit ◽  
...  

Cancer is the second leading cause of death worldwide. Aim of our study was to describe the spectrum of cancer among longlivers women in Lviv region (Ukraine) from database during 1991-2019. Material and methods. We studied 444 longlivers women aged 90+ who were diagnosed of cancer, treated and followed-up. Results. 104 women (23%) were diagnosed cancer to stage I, II -142 (32%), III -71 (10%), IV -57 (13%):other malignant neoplasms of skin (38.29%), breast (9.46%), colon (6.98%) and pancreas (4.95%) cancer. Diagnosis was confirmed cytology -169 (38.1%), histology-139 (31.3%). CT and MRI were used in rare cases in older women – 11(2.5%). Half of the women (227 or 51.13%) lived beyond 1 year after diagnosis. The rest is from 1 to 13 years. The relationship between life expectancy after diagnosis of cancer and type of treatment is weak (Сramer ratio ; Pearson's criterion ). Detected that the relationship between life expectancy after diagnosis and the age of patients at the time of oncologic diagnosis is weak too (Сramer ratio ; Pearson's criterion ). The relationship between life expectancy after diagnosis and stage of cancer is strong (Сramer ratio ; Pearson's criterion ). Conclusion. Aggressive anticancer treatments are less commonly used in cancer patients aged 90+, which may be one of the reasons for poorer survival due to comorbidities and natural causes. Life expectancy has relationship on the stage of the cancer, but does not have relationship on the age of the long-lived women and the type of treatment.

2016 ◽  
Vol 23 (4) ◽  
pp. 561-566 ◽  
Author(s):  
Nazim Serdar Turhal ◽  
Figen Akinci ◽  
Yasemin Haciabdullahoglu ◽  
Makbule Dolmaci ◽  
Ayse Sari ◽  
...  

Cancer, like other chronic illnesses, changes the patients’ way of living significantly. Although some may think, for instance, that religiousness would increase with the diagnosis of cancer, no previous studies have been performed in the Turkish society to confirm this. We, as the Turkish Oncology Group, conducted a survey in seven different oncology centres, representing a large majority of Turkey, to investigate how patients’ lifestyles changed following a cancer diagnosis; we used dialysis patients as a chronic illness control group. The study findings showed how changes in spiritual practices are completely in line with what is observed in other chronic illnesses. These findings may help to address cancer patients’ needs and facilitate resource allocation accordingly.


2018 ◽  
Vol 68 (suppl 1) ◽  
pp. bjgp18X696677
Author(s):  
Ruth Swann ◽  
ÒJana Witt ◽  
Brian Shand ◽  
Georgios Lyratzopoulos ◽  
Sara Hiom ◽  
...  

BackgroundAn earlier diagnosis of cancer can increase cancer survival and quality of life. Characterising avoidable delays to a patient’s diagnosis of cancer can help to direct quality improvement initiatives.AimTo evaluate avoidable delays to cancer diagnoses and the variation by cancer type and patient characteristics using primary care data collected as part of the National Cancer Diagnosis Audit (NCDA).MethodEnglish general practices participating in the NCDA (439) entered primary care data on patients (17,042) diagnosed with cancer in 2014. Using a taxonomy developed from the National Audit of Cancer Diagnosis in Primary Care (2011), GPs reported delays to the diagnosis that in their judgement were avoidable.ResultsIn 22% of NCDA patient records (n = 3380), the GP considered there to be an avoidable delay to the patient receiving their cancer diagnosis. There was variation by cancer type; 7% of breast cancer patients experienced delays compared to 34% of stomach cancer patients. 49% of avoidable delays occurred in primary care and 38% in secondary or tertiary care. Of all delays, 28% were attributed to clinician factors and 34% to health care system factors. Results will be presented by patient characteristics.ConclusionPrimary care data from the NCDA can be used to better understand potentially avoidable delays to diagnosis and identify possible solutions for improving the diagnostic pathway. Avoidable delays during cancer diagnosis occur for many reasons. These insights can inform quality improvement initiatives, which should be directed at both clinical and organisational factors in primary care and hospital settings.


2000 ◽  
Vol 15 (3) ◽  
pp. 119-122
Author(s):  
Bertrand Herer

The aim of the study was to determine the longevity of jazz musicians (JM) and their mortality patterns. The obituaries of subjects involved in jazz music were reviewed in a specialized periodical from 1990 to 1999. Age at death, sex, activity (JM or non-musicians [NM]), and estimation of life expectancy (LE) at birth were recorded. Causes of death were compared with a distribution based on the general U.S. population, and proportionate mortality ratios (PMRs) were calculated. The study population consisted of 346 decedents. The age at death was lower in JM than in NM (70.4 ± 12.4 vs 74.7 ± 10.4 years, p = 0.01), and 83.2% of JM exceeded their LE vs 93.3% of NM (p = 0.046). Information on the causes of death was available for 212 decedents. Malignant neoplasms were the leading cause of death in JM. The PMRs were elevated for malignant neoplasms and suicide. The longevity of JM is lower than that of nonmusical decedents involved in jazz music; however, death before predicted LE is uncommon. Based on this review, malignant neoplasms are the main cause of death in that socioprofessional category.


Biofeedback ◽  
2010 ◽  
Vol 38 (1) ◽  
pp. 24-27 ◽  
Author(s):  
Alice W. Inman

Abstract Cancer is the second leading cause of death in America. Because the majority of cancer patients today survive at least 5 years, cancer can be reconceptualized as a chronic illness. A diagnosis of cancer and subsequent treatment brings physical, emotional, and cognitive changes and challenges. Psycho-oncology is a relatively recent discipline that assists patients in coping with these changes. This article examines the experience of the human being facing cancer, and the potential role for behavioral professionals and biofeedback practitioners in assisting the cancer patient. There are certain periods during the cancer journey that appear to be more challenging. Biofeedback can assist patients in coping with these challenges.


2020 ◽  
Vol 58 (4) ◽  
pp. 72-77
Author(s):  
А. KHOZHAYEV ◽  
D. KAIDAROVA ◽  
А. DZHAKIPBAEVA ◽  
K. SMAGULOVA ◽  
N. AMANBEKOV ◽  
...  

Relevance: Today, the restorative treatment of patients with malignant neoplasms remains a relevant issue. This section of oncology is the most laborious and requires an integrated approach. The concept of Quality of Life (QoL) increasingly appears in clinical trials, along with survival. The study aimed to review the literature on various aspects of medical rehabilitation of cancer patients. Results: The selected sources analysis suggests the necessity of an integrated approach to the restorative treatment of cancer patients because the changes in these patients’ life status are often pronounced. These changes might involve the patient’s physical condition and its various functional indicators; psycho-emotional state, with the relationship between predictive perception, QoL and the patient’s mood; and the social status, which is decisive for the patient’s reintegration into society. Such a multilateral approach will cover all aspects of patients’ life activity and address the main focus of cancer patients’ medical rehabilitation – their QoL improvement. Conclusion: Implementation of an integrated medical rehabilitation program for cancer patients will promote a maximum possible restoration of these patients’ life conditions and facilitate their physical and psycho-social adaptation after specialized treatment.


2021 ◽  
Vol 42 (Supplement_1) ◽  
Author(s):  
J C Heemelaar ◽  
E A S Polomski ◽  
B J A Mertens ◽  
J W Jukema ◽  
M J Schalij ◽  
...  

Abstract Purpose To assess survival trends after ST-elevation myocardial infarction (STEMI) in patients with a prior cancer diagnosis and to evaluate the drivers of prognosis over a follow-up period of five years. Methods Patients with a known cancer diagnosis, admitted with STEMI between 2004–2014 and treated with primary PCI were recruited from the STEMI-clinical registry of our institution. Detailed information on cancer diagnosis, -stage, and treatment regimen were collected from the institutional and national cancer registry system and all patients were followed prospectively. Results In the 215 included patients the cumulative incidence of all-cause death after 5 years of follow-up was 38.2% (N=61). The cause of death was predominantly malignancy-related (N=29, 47.4% of deaths) and only 9 patients (14.8% of deaths) died of a cardiovascular cause. After correcting for age and sex – a recent cancer diagnosis (<1yr relative to >10 yr, HR 3.405 [95% CI: 1.552–7.470], p=0.002), distant metastasis at presentation (HR 2.603 [1.236–5.481], p=0.012), ongoing cancer treatment at presentation (HR 1.878 [1.015–3.475], p=0.045) and natural logarithm of maximum creatinine kinase level (HR 1.345 [1.044–1.733], p=0.022) were significant predictors of long-term mortality. While prevalent renal insufficiency showed significant association with all-cause mortality (HR 2.302 [1.289–4.111], p=0.005), other known determinants of long-term prognosis after STEMI – a history of diabetes mellitus (HR 1.250 [0.566–2.761], p=0.581), hypertension (HR 0.623 [0.393–1.085], p=0.150), and culprit vessel left anterior descending artery or left main artery (HR 1.066 [0.641–1.771], p=0.806) were not significantly associated with survival at 5-years follow-up. Conclusion Cancer patients admitted with STEMI have a poor survival with one third of patients died at 5 year follow up. Cancer was the most common cause of death and malignancy-related factors made a significant impact on prognosis, while most of the established cardiovascular determinants of prognosis were not significantly associated with long-term survival. FUNDunding Acknowledgement Type of funding sources: None. Cumulative incidence curve


2011 ◽  
Vol 29 (12) ◽  
pp. 1570-1577 ◽  
Author(s):  
Mara A. Schonberg ◽  
Edward R. Marcantonio ◽  
Long Ngo ◽  
Donglin Li ◽  
Rebecca A. Silliman ◽  
...  

Purpose To understand the impact of breast cancer on older women's survival, we compared survival of older women diagnosed with breast cancer with matched controls. Methods Using the linked 1992 to 2003 Surveillance, Epidemiology, and End Results (SEER) -Medicare data set, we identified women age 67 years or older who were newly diagnosed with ductal carcinoma in situ (DCIS) or breast cancer. We identified women not diagnosed with breast cancer from the 5% random sample of Medicare beneficiaries residing in SEER areas. We matched patient cases to controls by birth year and registry (99% or 66,039 patient cases matched successfully). We assigned the start of follow-up for controls as the patient cases' date of diagnosis. Mortality data were available through 2006. We compared survival of women with breast cancer by stage with survival of controls using multivariable proportional hazards models adjusting for age at diagnosis, comorbidity, prior mammography use, and sociodemographics. We repeated these analyses stratifying by age. Results Median follow-up time was 7.7 years. Differences between patient cases and controls in sociodemographics and comorbidities were small (< 4%). Women diagnosed with DCIS (adjusted hazard ratio [aHR], 0.7; 95% CI, 0.7 to 0.7) or stage I disease (aHR, 0.8; 95% CI, 0.8 to 0.8) had slightly lower mortality than controls. Women diagnosed with stage II disease or higher had greater mortality than controls (stage II disease: aHR, 1.2; 95% CI, 1.2 to 1.2). The association of a breast cancer diagnosis with mortality declined with age among women with advanced disease. Conclusion Compared with matched controls, a diagnosis of DCIS or stage I breast cancer in older women is associated with better survival, whereas a diagnosis of stage II or higher breast cancer is associated with worse survival.


2015 ◽  
Vol 11 (6) ◽  
pp. 429-434 ◽  
Author(s):  
Bruce C. Stuart ◽  
Amy J. Davidoff ◽  
Mujde Z. Erten

The authors found that a cancer diagnosis among patients with diabetes reduced adherence to evidence-based medications, particularly if patients' life expectancy was short.


2019 ◽  
Vol 82 (2) ◽  
pp. 155-162
Author(s):  
Teghan Lucas ◽  
Amrita Dhugga ◽  
Maciej Henneberg

Abstract Palmistry or Chiromancy is the art of reading lines on the palm of the hands. Today, many researchers believe that the lines on the palms of the hands can predict the individual’s future. Computer programs are being designed which can automatically read the lines on the palm of the hand. One popular theory is that the length of the line of life will indicate lifespan. This theory was investigated in 1974 by Wilson and Mather who found no significant correlation between life expectancy and the length of the line of life. In 1990 Newrick and colleagues found a significant correlation as measured on 100 cadavers. These conflicting investigations are the only existing studies which have explored the relationship between palmistry and longevity. Since then no other study has validated nor disproven these claims. A total of 60 cadavers donated to The University of Adelaide were used in this study. Total hand length and the line of life length were measured on all cadavers. The age at and cause of death were also recorded. Linear regressions were used to establish any correlations between longevity and the length of the line of life. No significant correlations were found. There was also no significant difference between males and females or the right or left hands. As no significant correlations were found between longevity and the line of life all efforts at producing more reliable and automatic ways to read the lines are futile. This study puts to rest any debate surrounding the use of the line of life in palmistry as introduced by Newrick and colleagues.


Sign in / Sign up

Export Citation Format

Share Document